ShockWave Medical, which sells medical systems used in treating cardiovascular disease, filed on Friday with the SEC to raise up to $70 million in an initial public offering.
The Santa Clara, CA-based company was founded in 2009 and booked $12 million in sales for the 12 months ended December 31, 2018. It plans to list on the Nasdaq under the symbol SWAV. ShockWave Medical filed confidentially on December 6, 2018. Morgan Stanley and BofA Merrill Lynch are the joint bookrunners on the deal. No pricing terms were disclosed.
